無症候性脳血管障害を解く

出版社： 文光堂
著者：
発行日： 2015-04-27
分野： 臨床医学：外科  >  脳神経外科学
ISBN： 9784830624056
電子書籍版： 2015-04-27 （第1版第2刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

20,900 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

20,900 円(税込)

購入する

商品紹介

脳神経外科が扱う無症候性脳血管障害の中で，特に重要なものに絞って，実際の診療の流れに沿うような形で，進歩の著しい画像診断による発症前診断と症候化のメカニズム，リスクファクターの管理，内科治療の管理，外科，血管内治療などの介入の適応などのエッセンスを豊富なイラストをもとに解説した．

目次

  • 無症候性脳血管障害を解く

    ―目次―

    I. 総説−「無症候性」の概念−
    　1．無症候性脳血管障害を解く─先制医療，適確医療の観点から─

    II. 無症候性脳血管障害のリスクファクター
    　1．総論─無症候性脳血管障害のリスクをどう捉えるか─
    　2．性差
    　3．高血圧─内服薬選択のコツ─
    　4．糖尿病─内服薬選択のコツ─
    　5．脂質異常症─内服薬選択のコツ─
    　6．喫煙
    　7．冠動脈病変─心脳連関とは？─
    　8．慢性腎臓病─脳腎連関とは？─
    　9．遺伝子異常
    　10．バイオマーカー

    III. 無症候性脳血管障害のイメージング
    　　　−症候化のメカニズムを解く−
    　1．総論─無症候性脳血管障害のイメージングの選定─
    　2．イメージングのリスク評価─造影剤と腎機能─
    　3．MRI─現状と未来─
    　4．MRI─大脳白質病変，認知症─
    　5．MRI─無症候性脳梗塞─
    　6．MRI─無症候性脳出血─
    　7．MRI─ivy sign─
    　8．MRI血管撮像─適応と限界─
    　9．MRIプラーク診断─どのように活用するか？─
    　10．超音波検査
    　11．経頭蓋ドプラ
    　12．カテーテル脳血管撮影
    　13．CT─機種の選定と読影のポイント─
    　14．CT血管造影─現状と未来─
    　15．PET/SPECT─脳循環代謝─
    　16．OCT，VH-IVUS
    　17．FDG-PET─炎症を可視化する─
    　18．分子イメージングの応用
    　19．computational fluid dynamics

    IV. 無症候性脳血管障害の内科治療と管理
    　1．脳ドック受診─高リスク患者への対応─
    　2．無症候性脳血管障害の内科治療─総論
    　3．無症候性脳血管障害が見つかったらどうするか？
    　　　─イメージングをどう活用し，病態を理解，管理するか？
    　4．無症候性脳血管障害を合併した患者の周術期管理

    V. 各論−外科治療，血管内治療の適応決定−
    　1．頸動脈狭窄症
    　2．頭蓋内狭窄
    　3．未破裂脳動脈瘤
    　4．海綿状血管腫
    　5．脳動静脈奇形
    　6．硬膜動静脈瘻
    　7．もやもや病
    　8．脳血管解離
    　9．脳静脈洞血栓症

    VI. 無症候性脳血管障害が与える影響
    　1．高次脳機能障害
    　2．Quality of life
    　3．医療経済効果─費用対効果を考えよう

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I. 総説 - 「無症候性」の概念 -

P.5 掲載の参考文献
1) Strategic vision for the future-from curative to pre-emptive medicine. http://www.nih.gov/strategicvision.htm
 
2) Katsnelson, A : Momentum grows to make 'personalized' medicine more 'precise'. Nat Med 2013 ; 19 : 249
 
3) 澤田徹 : 無症候性脳血管障害の診断基準に関する研究. 脳卒中 1998 ; 19 : 489-493
 
4) Greving, JP et al : Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms : a pooled analysis of six prospective cohort studies. Lancet Neurol 2014 ; 13 : 59-66
 
5) Friedman, JI et al : Brain imaging changes associated with risk factors for cardiovascular and cerebrovascular disease in asymptomatic patients. JACC Cardiovasc Imaging 2014 ; 7 : 1039-1053
 
6) Vermeer, SE et al : Silent brain infarcts : a systematic review. Lancet Neurol 2007 ; 6 : 611-619
 
7) Shinkawa, A et al : Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study. Stroke 1995 ; 26 : 380-385
 
8) Yamada, N et al : Association between signal hyperintensity on T1-weighted MR imaging of carotid plaques and ipsilateral ischemic events. AJNR Am J Neuroradiol 2007 ; 28 : 287-292
 
9) Tahara, N et al : Simvastatin attenuates plaque inflammation : evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006 ; 48 : 1825-1831
 
10) Ritter, MA et al : Prevalence and prognostic impact of microembolic signals in arterial sources of embolism. A systematic review of the literature. J Neurol 2008 ; 255 : 953-961
 
11) Noguchi, T et al : High-intensity signals in carotid plaques on T1-weighted magnetic resonance imaging predict coronary events in patients with coronary artery disease. J Am Coll Cardiol 2011 ; 58 : 416-422
 
12) Takao, H et al : Hemodynamic differences between unruptured and ruptured intracranial aneurysms during observation. Stroke 2012 ; 43 : 1436-1439
 
13) Hasan, DM et al : Macrophage imaging within human cerebral aneurysms wall using ferumoxytol-enhanced MRI : a pilot study. Arterioscler Thromb Vasc Biol 2012 ; 32 : 1032-1038
 

II. 無症候性脳血管障害のリスクファクター

P.11 掲載の参考文献
1) Shinkawa, A et al : Silent cerebral infarction in a community-based autopsy series in Japan. Stroke 1995 ; 26 : 380-385
 
2) Vermeer, SE et al : Silent brain infarcts : a systematic review. Lancet Neurol 2007 ; 6 : 611-619
 
3) Kovacs, KR et al : Silent brain infarction-a review of recent observations. Int J Stroke 2013 ; 8 : 334-347
 
4) Fanning, JP et al : The epidemiology of silent brain infarction : a systemic review of population-based cohorts. BMC Med 2014 ; 12 : 119
 
5) Vermeer, SE et al : Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2002 ; 33 : 21-25
 
6) Das, RR et al : Prevalence and correlates of silent cerebral infarcts in the Framingham Offspring Study. Stroke 2008 ; 39 : 2929-2935
 
7) Poels, MMF et al : Incidence of cerebral microbleeds in the general population : The Rotterdam Scan Study. Stroke 2011 ; 42 : 656-661
 
8) Romero, JR et al : Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke 2014 ; 45 : 1492-1494
 
9) Vermeer, SE et al : Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2003 ; 34 : 392-396
 
10) Kobayashi, M et al : Relationship between silent brain infarction and chronic kidney disease. Nephrol Dial Transplant 2009 ; 24 : 201-207
 
P.15 掲載の参考文献
1) Cheanvechai, V et al : Incidence of peripheral vascular disease in women : is it different from that in men? J Thorac Cardiovasc Surg 2004 ; 127 : 314-317
 
2) Carandang, R et al : Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 2006 ; 296 : 2939-2946
 
3) Turin, TC et al : Lifetime risk of stroke in Japan. Stroke 2010 ; 41 : 1552-1554
 
4) Turin TC, et al : Lifetime risk of acute myocardial infarction in Japan. Circ Cardiovasc Qual Outcomes 2010 ; 3 : 701-703
 
5) Higashiyama, A et al : Risk of smoking and metabolic syndrome for incidence of cardiovascular disease -comparison of relative contribution in urban Japanese population : the Suita study. Circ J 2009 ; 73 : 2258-2263
 
P.19 掲載の参考文献
1) 日本高血圧学会治療ガイドライン作成委員会 : 高血圧治療ガイドライン 2014, ライフサイエンス出版, 東京, 2014
 
2) Benavente, OR et al : Blood-pressure targets in patients with recent lacunar stroke : the SPS3 randomised trial. Lancet 2013 ; 382 : 507-515
 
3) PROGRESS Collaboration Group : Randomised trial of a perindopril-based blood-pressure-lowering regimenamong 6,105 individuals with previous stroke or transient ischemic attack. Lancet 2001 ; 358 : 1033-1041
 
4) Kimura, Y et al : Hemodynamic influence of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions. Hypertens Res 2008 ; 31 : 2147-2154
 
5) Wang, JG et al : Carotid intima-media thickness and antihypertensive treatment : a meta-analysis of randomized controlled trials. Stroke 2006 ; 37 : 1933-1940
 
P.27 掲載の参考文献
1) Brownlee, M : Biochemistry and molecular cell biology of diabetic complications. Nature 2001 ; 414 : 813-820
 
2) Vermeer, SE et al : Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2003 ; 34 : 392-396
 
3) Eguchi, K et al : Greater impact of coexistence of hypertension and diabetes on silent cerebral infarcts. Stroke 2003 ; 34 : 2471-2474
 
4) Woerdeman, J et al : Proliferative retinopathy in type 1 diabetes is associated with cerebral microbleeds, which is part of generalized microangiopathy. Diabetes Care 2014 ; 37 : 1165-1168
 
5) Ray, KK et al : Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus : a meta-analysis of randomised controlled trials. Lancet 2009 ; 373 : 1765-1772
 
6) Zhang, C et al : Efficacy of intensive control of glucose in stroke prevention : a meta-analysis of data from 59, 197 participants in 9 randomized controlled trials. PLoS One 2013 ; 8 : e54465
PubMed
7) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998 ; 352 : 854-865
 
P.33 掲載の参考文献
1) Imamura, T et al : LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population : the Hisayama Study. Stroke 2009 ; 40 : 382-388
 
2) Nakamura, H et al : Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study) : a prospective randomised controlled trial. Lancet 2006 ; 368 : 1155-1163
 
3) Amarenco, P et al : Results of the Stroke Prevention by Aggressive Reduction in Cholesteral Levels (SPARCL) trial by stroke subtypes. Stroke 2009 ; 40 : 1405-1409
 
4) Nagai, Y et al : Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke : the Japan Statin Treatment Against Recurrent Stroke (J-STARS). Int J Stroke 2014 ; 9 : 232-239
 
5) Nakaya N et al : Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low dose simvastatin in Japanese patients with hypercholesterolemia : sub-analysis of the Japan Lipid Intervention Trial (J-LIT). Circ J 2005 ; 69 : 1016-1021
 
6) Tanaka K et al : Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients : subanalysis of the JELIS trial. Stroke 2008 ; 39 : 2052-2058
 
P.37 掲載の参考文献
1) Shinton, R et al : Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989 ; 298 : 789-794
 
2) Mannami, T et al : Cigarette smoking and risk of stroke and its subtypes among middle-aged Japanese men and women : the JPHC Study Cohort I. Stroke 2004 ; 35 : 1248-1253
 
3) de Weerd, M et al : Prediction of asymptomatic carotid artery stenosis in the general population : identification of high-risk groups. Stroke 2014 ; 45 : 2366-2371
 
4) Sanada, S et al : Smoking promotes subclinical atherosclerosis in apparently healthy men : 2-year ultrasonographic follow-up. Circ 2012 ; 76 : 2884-2891
 
5) Feigin, VL et al : Risk factors for subarachnoid hemorrhage : an updated systematic review of epidemiological studies. Stroke 2005 ; 36 : 2773-2780
 
6) Hata, J et al : Combined effects of smoking and hypercholesterolemia on the risk of stroke and coronary heart disease in Japanese : the Hisayama study. Cerebrovasc Dis 2011 ; 31 : 477-484
 
7) Juvela, S et al : Factors affecting formation and growth of intracranial aneurysms : a long-term follow-up study. Stroke 2001 ; 32 : 485-491
 
8) Wolf, PA et al : Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 1988 ; 259 : 1025-1029
 
9) Iso, H et al : Smoking cessation and mortality from cardiovascular disease among Japanese men and women : the JACC Study. Am J Epidemiol 2005 ; 161 : 170-179
 
10) Juvela, S et al : Natural history of unruptured intracranial aneurysms : a long-term follow-up study. Stroke 2013 ; 44 : 2414-2421
 
P.41 掲載の参考文献
1) Steg, PG et al : One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007 ; 297 : 1197-1206
 
2) Uehara, T et al : Asymptomatic occlusive lesions of carotid and intracranial arteries in Japanese patients with ischemic heart disease : evaluation by brain magnetic resonance angiography. Stroke 1996 ; 27 : 393-397
 
3) Tanimoto, S et al : Prevalence of carotid artery stenosis in patients with coronary artery disease in Japanese population. Stroke 2005 ; 36 : 2094-2098
 
4) Slark, J et al : Silent brain infarction in the presence of systemic vascular disease. JRSM Cardiovasc Dis 2012 ; 1 : 3. DOI 10.1258
 
5) Shimada, T : Prediction of coronary artery disease in patients undergoing carotid endarterectomy. J Neurosurg 2005 ; 103 : 593-596
 
6) Steinvil, A et al : Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease. J Am Coll Cardiol 2011 ; 57 : 779-783
 
7) Moody, AR et al : Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 2003 ; 107 : 3047-3052
 
8) Noguchi, T et al : High-intensity signals in carotid plaques on T1-weighted magnetic resonance imaging predict coronary events in patients with coronary artery disease. J Am Coll Cardiol 2011 ; 58 : 416-422
 
9) Kim, BJ et al : Advanced coronary artery calcification and cerebral small vessel disease in the healthy elderly. Circ J 2011 ; 75 : 451-456
 
P.45 掲載の参考文献
1) Toyoda, K : The cerebro-renal interaction in stroke neurology. Neurology 2012 ; 78 : 1898-1899
 
2) Toyoda, K ed : Brain, Stroke and Kidney, Karger, Basel, 2013
 
3) Toyoda, K : Cerebrorenal interaction and stroke. Contrib Nephrol 2013 ; 179 : 1-6
 
4) Toyoda, K et al : Stroke and cerebrovascular diseases in patients with chronic kidney disease. Lancet Neurol 2014 ; 13 : 823-833
 
5) Toyoda, K : Cerebral small vessel disease and chronic kidney disease. J Stroke 2015 ; 17 : 31-37
 
6) Lee, M et al : Low glomerular filtration rate and risk of stroke : meta-analysis. BMJ 2010 ; 341 : c4249
PubMed
7) Ninomiya, T et al : Proteinuria and stroke : a meta-analysis of cohort studies. Am J Kidney Dis 2009 ; 53 : 417-425
 
8) Kumai, Y et al : Proteinuria and clinical outcomes after ischemic stroke. Neurology 2012 ; 78 : 1909-1915
 
9) Kuwashiro, T et al : Risk factors predisposing to stroke recurrence within one year of non-cardioembolic stroke onset : the Fukuoka Stroke Registry. Cerebrovasc Dis 2012 ; 33 : 141-149
 
10) Miyagi, T et al : Reduced estimated glomerular filtration rate affects outcomes 3 months after intracerebral hemorrhage : the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study. J Stroke Cerebrovasc Dis 2015 ; 24 : 176-182
 
11) Hirano, T : Thrombolysis and hyperacute reperfusion therapy for stroke in renal patients. Contrib Nephrol 2013 ; 179 : 110-118
 
12) Seliger, SL et al : Cystatin C and subclinical brain infarction. J Am Soc Nephrol 2005 ; 16 : 3721-3727
 
13) Ikram, MA et al : Kidney function is related to cerebral small vessel disease. Stroke 2008 ; 39 : 55-61
 
14) Wada, M et al : Cerebral small vessel disease and chronic kidney disease (CKD) : results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci 2008 ; 272 : 36-42
 
15) Khatri, M et al : Chronic kidney disease is associated with white matter hyperintensity volume : The Northern Manhattan Study (NOMAS). Stroke 2007 ; 38 : 3121-3126
 
16) Ikram, MA et al : Unrecognized myocardial infarction in relation to risk of dementia and cerebral small vessel disease. Stroke 2008 ; 39 : 1421-1426
 
17) Shima, H et al : Cerebral microbleeds in predialysis patients with chronic kidney disease. Nephrol Dial Transplant 2010 ; 25 : 1554-1559
 
18) Ovbiagele, B et al : Strong independent correlation of proteinuria with cerebral microbleeds in patients with stroke and transient ischemic attack. Arch Neurol 2010 ; 67 : 45-50
 
19) Ohara, T et al : Impact of chronic kidney disease on carotid atherosclerosis according to blood pressure category : The Suita Study. Stroke 2013 ; 44 : 3537-3539
 
20) Kurella Tamura, M et al : Kidney function and cognitive impairment in US adults : the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis 2008 ; 52 : 227-234
 
21) Helmer, C et al : Chronic kidney disease, cognitive decline, and incident dementia : The 3C Study. Neurology 2011 ; 77 : 2043-2051
 
22) Miwa, K et al : Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease. Neurology 2014 ; 82 : 1051-1057
 
P.50 掲載の参考文献
1) 日本医学会 : 医療における遺伝学的検査・診断に関するガイドライン (2011). http://jams.ed.or.jp/guideline/genetics-diagnosis.pdf
 
2) Majersik, JJ et al : Single-gene stroke disorders. Semin Neurol 2006 ; 26 : 33-48
 
3) Ballabio E et al : Monogenic vessel diseases related to ischemic stroke : a clinical approach. J Cereb Blood Flow Metab 2007 ; 27 : 1649-1662
 
4) Gene Reviews Japan. http://grj.umin.jp
 
5) 小嶋哲人 : 血栓性疾患 先天性凝固阻止因子欠乏症 (antithrombin, protein C, protein S欠損症). 血栓止血誌 2009 ; 20 : 484-486
 
P.56 掲載の参考文献
1) Abbott, NJ : Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis 2013 ; 36 : 437-449
 
2) Pantoni, L : Cerebral small vessel disease : from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010 ; 9 : 689-701
 
3) Gouw, AA et al : Heterogeneity of small vessel disease : a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011 ; 82 : 126-135
 
4) Kumai, Y et al : Proteinuria and clinical outcomes after ischemic stroke. Neurology 2012 ; 78 : 1909-1915
 
5) Ross, R : Atherosclerosis-an inflammatory disease. N Engl J Med 1999 ; 340 : 115-126
 
6) Kuwashiro, T et al : Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke-Research for Biomarkers in Ischemic Stroke (REBIOS). Metabolism 2014 ; 63 : 1093-1103
 
7) Ridker, PM : Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003 ; 107 : 363-369
 

III. 無症候性脳血管障害のイメージング - 症候化のメカニズムを解く -

P.63 掲載の参考文献
1) 澤田徹ほか : 無症候性脳血管障害の診断基準に関する研究. 脳卒中 1998 ; 19 : 489-493
 
2) 細矢貴亮ほか編 :研修医必携 救急で役立つ頭部CT・MRI, 南江堂, 東京, 2006
 
3) Moreau, F et al : Cavitation after acute symptomatic lacunar stroke depends on time, location, and MRI sequence. Stroke 2012 ; 43 : 1837-1842
 
4) 佐々木真理 : 神経系のMR撮像法. 日磁医誌 1999 ; 19 : 503-519
 
5) 日本脳ドック学会 : 脳ドックのガイドライン 2014, 改訂第4版, 響文社, 札幌, 2014
 
6) 岡田靖ほか : 無症候性脳内出血MRI所見からの検討. 脳卒中 1992 ; 14 : 187-191
 
7) Cordonnier, C et al : Spontaneous brain microbleeds : Systematic review, subgroup analysis and standards for study design and reporting. Brain 2007 ; 130 : 1988-2003
 
8) Greenberg, SM et al : Cerebral microbleeds : A guide to detection and interpretation. Lancet Neurol 2009 ; 8 : 165-174
 
9) Fazekas, F et al : Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage : Evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999 ; 20 : 637-642
 
10) Charidimou, A et al : Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk. Front Neurol 2012 ; 3 : 133
PubMed
11) Wardlaw, JM et al : Mechanisms of sporadic cerebral small vessel disease : insights from neuroimaging. Lancet Neurol 2013 ; 12 : 483-497
 
12) Chabriat, H et al : CADASIL. Lancet Neurol 2009 ; 8 : 643-653
 
13) Yamada, N et al : Association between signal hyperintensity on T1-weighted MR imaging of carotid plaques and ipsilateral ischemic events. AJNR Am J Neuroradiol 2007 ; 28 : 287-292
 
14) Korogi, Y et al : MR angiography of intracranial aneurysms : a comparison of 0.5T abd 1.5T. Comput Med Imaging Graph 1997 ; 21 : 111-116
 
15) Leclerc, X et al : Internal carotid arterial stenosis : CT angiography with volume rendering. Radiology 1999 ; 210 : 673-682
 
16) Van Beijum, J et al : Treatment of brain arteriovenous malformation : A systematic review and meta-analysis. JAMA 2011 ; 306 : 2011-2019
 
17) Morris, Z et al : Incidental findings on brain magnetic resonance imaging : systematic review and meta-analysis. BMJ 2009 ; 339 : b3016
PubMed
P.67 掲載の参考文献
1) 大野岩男ほか : 造影剤腎症の定義. 腎障害患者におけるヨード造影剤使用に関するガイドライン, 東京医学社, 東京, 2012, 3-5
 
2) 糖尿病性腎症に関する合同委員会 : 糖尿病性腎症診療のガイドライン. 日腎会誌 2005 ; 47 : 767-769
 
3) Brar, SS et al : Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury : the POSEIDON randomised controlled trial. Lancet 2014 ; 383 : 1814-1823
 
P.77 掲載の参考文献
1) Fazekas, F et al : The morphologic correlate of incidental punctate white matter hyperintensities on MR images. AJNR Am J Neuroradiol 1991 ; 12 : 915-921
 
2) Kim, KW et al : Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol Psychiatry 2008 ; 64 : 273-280
 
3) Debette, S et al : The clinical importance of white matter hyperintensities on brain magnetic resonance imaging : systematic review and meta-analysis. BMJ 2010 ; 341 : c3666
PubMed
4) Vermeer, SE et al : Silent brain infarcts and white matter lesions increase stroke risk in the general population : the Rotterdam Scan Study. Stroke 2003 ; 34 : 1126-1129
 
5) Gorelick, PB et al : Vascular contributions to cognitive impairment and dementia : a statement for healthcare professionals from the american heart association/american stroke association. Stroke 2011 ; 42 : 2672-2713
 
P.84 掲載の参考文献
1) Droste, DW et al : Clinically silent circulating microemboli in 20 patients with carotid or vertebral artery dissection. Cerebrovasc Dis 2001 ; 12 : 181-185
 
2) Pantoni, L : Cerebral small vessel disease : from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010 ; 9 : 689-701
 
3) Thal DR, et al : Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathol 2008 ; 115 : 599-609
 
4) Zhu, YC et al : Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging. J Neurol 2012 ; 259 : 530-536
 
5) Soontornniyomkij, V et al : Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy. Brain Pathol 2010 ; 20 : 459-467
 
6) Haglund, M et al : Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia. Acta Neuropathol 2006 ; 111 : 430-435
 
7) Ellis, RJ et al : Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease : the CERAD experience, Part XV. Neurology 1996 ; 46 : 1592-1596
 
8) Weller, RO et al : Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol 2008 ; 18 : 253-266
 
9) Tomimoto, H et al : Vascular changes in white matter lesions of Alzheimer's disease. Acta Neuropathol 1999 ; 97 : 629-634
 
10) Tian, J et al : Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer's disease. Neuropathol Appl Neurobiol 2004 ; 30 : 46-56
 
11) Charidimou, A et al : Sporadic cerebral amyloid angiopathy revisited : recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 2012 ; 83 : 124-137
 
12) Boiten, J et al : Two clinically distinct lacunar infarct entities? A hypothesis. Stroke 1993 ; 24 : 652-656
 
13) Wen, L et al : Heterogeneity of single small subcortical infarction can be reflected in lesion location. Neurol Sci 2013 ; 34 : 1109-1116
 
14) Yamamoto, Y et al : Diminished nocturnal blood pressure decline and lesion site in cerebrovascular disease. Stroke 1995 ; 26 : 829-833
 
15) 山本康正ほか : 脳梗塞臨床の第一線における問題点 : Branch atheromatous disease (BAD) をどう考え, どう対処するかBranch atheromatous disease (BAD) の概念とその臨床的意義. 臨床神経 2010 ; 50 : 914-917
 
16) Vermeer, SE et al : Silent brain infarcts and white matter lesions increase stroke risk in the general population : the Rotterdam Scan Study. Stroke 2003 ; 34 : 1126-1129
 
17) Bernick, C et al : Silent MRI infarcts and the risk of future stroke : the cardiovascular health study. Neurology 2001 ; 57 : 1222-1229
 
18) Bokura, H et al : Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality : a prospective cohort study. J Stroke Cerebrovasc Dis 2006 ; 15 : 57-63
PubMed
19) Vermeer, SE et al : Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003 ; 348 : 1215-1222
 
20) Wright, CB et al : White matter hyperintensities and subclinical infarction : associations with psychomotor speed and cognitive flexibility. Stroke 2008 ; 39 : 800-805
 
21) Mangla, R et al : Border zone infarcts : pathophysiologic and imaging characteristics. Radiographics 2011 ; 31 : 1201-1214
 
22) Moustafa, RR et al : Microembolism versus hemodynamic impairment in rosary-like deep watershed infarcts : a combined positron emission tomography and transcranial Doppler study. Stroke 2011 ; 42 : 3138-3143
 
23) Lee, PH et al : Subcortical white matter infarcts : comparison of superficial perforating artery and internal border-zone infarcts using diffusion-weighted magnetic resonance imaging. Stroke 2003 ; 34 : 2630-2635
 
P.88 掲載の参考文献
1) Kinoshita, T et al : Assessment of lacunar hemorrhage associated with hypertensive stroke by echo-planar gradient-echo T2*-weighted MRI. Stroke 2000 ; 31 : 1646-1650
 
2) Greenberg, SM et al : Cerebral microbleeds : a guide to detection and interpretation. Lancet Neurol 2009 ; 8 : 165-174
 
3) Cheng, AL et al : Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds. Stroke 2013 ; 44 : 2782-2786
 
4) Nandigam RN, et al : MR imaging detection of cerebral microbleeds : effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol 2009 ; 30 : 338-343
 
P.93 掲載の参考文献
1) Ohta, T et al : Diffuse leptomeningeal enhancement, "ivy sign," in magnetic resonance images of moyamoya disease in childhood : Case report. Neurosurgery 1995 ; 37 : 1009-1012
 
2) Kaku, Y et al : The leptomeningeal ivy sign on fluid-attenuated inversion recovery images in moyamoya disease : Positron emission tomography study. Cerebrovasc Dis 2013 ; 36 : 19-25
 
3) Mori, N et al : The leptomeningeal "ivy sign" on fluid-attenuated inversion recovery MR imaging in moyamoya disease : A sign of decreased cerebral vascular reserve? AJNR Am J Neuroradiol 2009 ; 30 : 930-935
 
4) Horie, N et al : De novo ivy sign indicates postoperative hyperperfusion in moyamoya disease. Stroke 2014 ; 45 : 1488-1491
 
5) Kawashima, M et al : Decrease in leptomeningeal ivy sign on fluid-attenuated inversion recovery images after cerebral revascularization in patients with moyamoya disease. AJNR Am J Neuroradiol 2010 ; 31 : 1713-1718
 
P.98 掲載の参考文献
1) Fujii, Y et al : High-resolution T2-reversed magnetic resonance imaging on a high magnetic field system. Technical note. J Neurosurg 1998 ; 89 : 492-495
 
2) Katada K : MR imaging of brain surface structures : surface anatomy scanning (SAS). Neuroradiology 1990 ; 32 : 439-448
 
3) 長畑守雄ほか : Basi-parallel anatomical scanning (BPAS) MRIによる椎骨脳底動脈の概観表示. 日本医放会誌 2003 ; 63 : 582-584
 
4) Sorimachi, T et al : A true posterior communicating artery aneurysm : variations in the relationship between the posterior communicating artery and the oculomotor nerve. Case illustration. J Neurosurg 2004 ; 100 : 353
PubMed
5) Morita, K et al : Thrombosing aneurysm diagnosed with contrast-enhanced MR angiography. Acta Neurochir (Wien) 2001 ; 143 : 845-846
 
6) Sorimachi, T et al : Postangiographic 3D CT findings of a thrombosed dissecting aneurysm of the posterior inferior cerebellar artery. AJNR Am J Neuroradiol 2004 ; 25 : 973-974
 
P.102 掲載の参考文献
1) Stary, HC et al : A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, american heart association. Circulation 1995 ; 92 : 1355-1374
 
2) Saam, T et al : Meta-analysis and systematic review of the predictive value of carotid plaque hemorrhage on cerebrovascular events by magnetic resonance imaging. J Am Coll Cardiol 2013 ; 62 : 1081-1091
 
3) Gupta, A et al : Carotid plaque MRI and stroke risk : A systematic review and meta-analysis. Stroke 2013 ; 44 : 3071-3077
 
4) Bayer-Karpinska, A et al : The carotid plaque imaging in acute stroke (capias) study : Protocol and initial baseline data. BMC Neurol 2013 ; 13 : 201
PubMed
5) Millon, A et al : Clinical and histological significance of gadolinium enhancement in carotid atherosclerotic plaque. Stroke 2012 ; 43 : 3023-3028
 
P.108 掲載の参考文献
1) Terminology and Diagnostic Criteria Committee : Standard method for ultrasound evaluation of carotid artery lesions. Jpn J Med Ultrasonics. 2009 ; 36 : 501-518
 
2) Touboul, PJ et al : Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 2012 ; 34 : 290-296
 
3) Koga, M et al : Diagnosis of internal carotid artery stenosis greater than 70% with power doppler duplex sonography. AJNR Am J Neuroradiol 2001 ; 22 : 413-417
 
4) Kakkos, SK et al : Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis. J Vasc Surg 2014 ; 59 : 956-967
PubMed
5) Saito, K et al : Contrast-enhanced ultrasound for the evaluation of neovascularization in atherosclerotic carotid artery plaques. Stroke 2014 ; 45 : 3073-3075
 
P.113 掲載の参考文献
1) Markus, HS et al : Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection : the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005 ; 111 : 2233-2240
 
2) Sliwka, U et al : Prevalence and time course of microembolic signals in patients with acute stroke. A prospective study. Stroke 1997 ; 28 : 358-363
 
3) Iguchi, Y et al : Microembolic signals at 48 hours after stroke onset contribute to new ischaemia within a week. J Neurol Neurosurg Psychiatry 2008 ; 79 : 253-259
 
4) Iguchi, Y et al : Microembolic signals after 7 days but not within 24 hours of stroke onset should be predictor of stroke recurrence. J Neurol Sci 2007 ; 263 : 54-58
 
5) Ritter, MA et al : Prevalence and prognostic impact of microembolic signals in arterial sources of embolism. A systematic review of the literature. J Neurol 2008 ; 255 : 953-961
 
6) Iguchi, Y et al : Microembolic signals are associated with progression of arterial lesion in Moyamoya disease : a case report. J Neurol Sci 2007 ; 260 : 253-255
 
7) Chen, J et al : Microembolic signals predict cerebral ischaemic events in patients with moyamoya disease. Eur J Neurol 2014 ; 21 : 785-790
 
8) Iguchi, Y et al : Spontaneous recanalization at subacute phase of stroke may be dramatic : A case report. J Neurol Sci 2007 ; 252 : 92-95
 
9) Kobayashi, K et al : Contrast transcranial Doppler can diagnose large patent foramen ovale. Cerebrovasc Dis 2009 ; 27 : 230-234
 
10) Meier, B et al : Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013 ; 368 : 1083-1091
 
P.119 掲載の参考文献
1) Katayama, H et al : Adverse reactions to ionic and nonionic contrast media. Radiology 1990 ; 175 : 621-628
 
2) Pannu, N et al : Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006 ; 295 : 2765-2779
 
P.124 掲載の参考文献
1) Gupta, R et al : Evaluation of dual-energy CT for differentiating intracerebral hemorrhage from iodinated contrast material staining. Radiology 2010 ; 257 : 205-211
 
2) Barber, PA et al : Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000 ; 355 : 1670-1674
 
P.129 掲載の参考文献
1) van Gelder, JM : Computed tomographic angiography for detecting cerebral aneurysms : implications of aneurysm size distribution for the sensitivity, specificity, and likelihood ratios. Neurosurgery 2003 ; 53 : 597-605 ; discussion 605-606
 
2) Harrison, MJ et al : Preliminary results on the management of unruptured intracranial aneurysms with magnetic resonance angiography and computed tomographic angiography. Neurosurgery 1997 ; 40 : 947-955 ; discussion 955-957
 
3) Murayama, K et al : Whole-brain perfusion CT performed with a prototype 256-detector row CT system : initial experience. Radiology 2009 ; 250 : 202-211
 
4) Hayakawa, M et al : Detection of pulsation in unruptured cerebral aneurysms by ECG-gated 3D-CT angiography (4D-CTA) with 320-row area detector CT (ADCT) and follow-up evaluation results : assessment based on heart rate at the time of scanning. Clin Neuroradiol 2014 ; 24 : 145-150
 
5) Gervaise, A et al : CT image quality improvement using adaptive iterative dose reduction with wide-volume acquisition on 320-detector CT. Eur Radiol 2012 ; 22 : 295-301
 
P.133 掲載の参考文献
1) Yamauchi, H et al : Chronic hemodynamic compromise and cerebral ischemic events in asymptomatic or remote symptomatic large-artery intracranial occlusive disease. AJNR Am J Neuroradiol 2013 ; 34 : 1704-1710
PubMed
2) Yamauchi, H et al : Long-term changes of hemodynamics and metabolism after carotid artery occlusion. Neurology 2000 ; 54 : 2095-2102
 
3) Yamauchi, H et al : Crossed cerebellar hypoperfusion indicates the degree of uncoupling between blood flow and metabolism in major cerebral arterial occlusion. Stroke 1994 ; 25 : 1945-1951
 
4) Yamauchi, H et al : Impaired perfusion modifies the relationship between blood pressure and stroke risk in major cerebral artery disease. J Neurol Neurosurg Psychiatry 2013 ; 84 : 1226-1232
 
P.137 掲載の参考文献
1) 菱川朋人ほか : 頚動脈プラークイメージングの現状と展望. 脳外誌 2010 ; 19 : 836-843
 
2) Yoshimura, S et al : Visualization of internal carotid artery atherosclerotic plaque in symptomatic and asymptomatic patients : A comparison of optical coherence tomography and intravascular ultrasound. AJNR Am J Neuroradiol 2012 ; 33 : 308-313
 
3) Matsumoto, S et al : Fibro-fatty volume of culprit lesions in virtual histology intravascular ultrasound is associated with the amount of debris during carotid artery stenting. Cerebrovasc Dis 2010 ; 29 : 468-475
 
4) Hishikawa, T et al : Virtual histology-intravascular ultrasound in assessment of carotid plaques : Ex vivo study. Neurosurgery 2009 ; 65 : 146-152
 
5) Hishikawa, T et al : Assessment of necrotic core with intraplaque hemorrhage in atherosclerotic carotid artery plaque by MR imaging with 3D gradient-echo sequence in patients with high-grade stenosis. J Neurosurg 2010 ; 113 : 890-896
 
P.145 掲載の参考文献
1) Iso, H et al : The impact of C-reactive protein on risk of stroke, stroke subtypes, and ischemic heart disease in middle-aged Japanese : the Japan public health center-based study. J Atheroscler Thromb 2012 ; 19 : 756-766
 
2) Rudd, JH et al : Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography : ready for prime time? J Am Coll Cardiol 2010 ; 55 : 2527-2535
 
3) Kubota, R et al : Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo : high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992 ; 33 : 1972-1980
 
4) Folco, EJ et al : Hypoxia but not inflammation augments glucose uptake in human macrophages : Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. J Am Coll Cardiol 2011 ; 58 : 603-614
 
5) Ogawa, M et al : What can be seen by 18F-FDG PET in atherosclerosis imaging? The effect of foam cell formation on 18F-FDG uptake to macrophages in vitro. J Nucl Med 2012 ; 53 : 55-58
 
6) Tawakol, A et al : In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006 ; 48 : 1818-1824
 
7) Rudd, JH et al : (18) Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible : implications for atherosclerosis therapy trials. J Am Coll Cardiol 2007 ; 50 : 892-896
 
8) Tahara, N et al : Simvastatin attenuates plaque inflammation : evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006 ; 48 : 1825-1831
 
9) Tahara, N et al : Demonstration of the efficacy of statins in resolution of plaque inflammation by serial FDG imaging. Immun, Endoc & Metab Agents in Med Chem 2008 ; 8 : 183-188
 
10) Mizoguchi, M et al : Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta. JACC Cardiovasc Imaging 2011 ; 4 : 1110-1118
PubMed
11) Igata, S et al : Demonstration of the disease activity by serial carotid artery ultrasonography, magnetic resonance imaging and 18-fluoro-deoxyglucose positron emission tomography in a Behcet's disease patient with carotid artery stenosis. Eur Heart J 2015 (in press)
 
12) Tahara, N et al : The prevalence of inflammation in carotid atherosclerosis : analysis with fluorodeoxyglucose-positron emission tomography. Eur Heart J 2007 ; 28 : 2243-2248
 
13) Tahara, N et al : Vascular inflammation evaluated by [18F] -fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol 2007 ; 49 : 1533-1539
 
14) Dormandy, JA et al : Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events) : a randomised controlled trial. Lancet 2005 ; 366 : 1279-1289
 
15) Wilcox, R et al : PROactive Investigators : Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke : results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04). Stroke 2007 ; 38 : 865-873
 
16) Soyama, Y et al : High-density lipoprotein cholesterol and risk of stroke in Japanese men and women : the Oyabe Study. Stroke 2003 ; 34 : 863-868
 
17) Fayad, ZA et al : Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE) : a randomised clinical trial. Lancet 2011 ; 378 : 1547-1559
 
18) Schwartz, GG et al : Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012 ; 367 : 2089-2099
 
19) Khera, AV et al : Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011 ; 364 : 127-135
 
P.149 掲載の参考文献
1) Tada, Y et al : Roles of hypertension in the rupture of intracranial aneurysms. Stroke 2014 ; 45 : 579-586
 
2) Hasan, DM et al : Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke 2011 ; 42 : 3156-3162
 
3) Hasan, DM et al : Macrophage imaging within human cerebral aneurysms wall using ferumoxytol-enhanced MRI : a pilot study. Arterioscler Thromb Vasc Biol 2012 ; 32 : 1032-1038
 
4) Hasan, D et al : Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm : a pilot study. Stroke 2012 ; 43 : 3258-3265
 
5) Ogasawara, Y et al : Preoperative 123I-iomazenil SPECT imaging predicts cerebral hyperperfusion following endarterectomy for unilateral cervical internal carotid artery stenosis. Am J Nucl Med Mol Imaging 2012 ; 2 : 77-87
 
P.154 掲載の参考文献
1) Meng, H et al : High WSS or low WSS? Complex interactions of hemodynamics with intracranial aneurysm initiation, growth, and rupture : toward a unifying hypothesis. AJNR Am J Neuroradiol 2014 ; 35 : 1254-1262
 
2) Xiang, J et al : CFD : Computational fluid dynamics or confounding factor dissemination? The role of hemodynamics in intracranial aneurysm rupture risk assessment. AJNR Am J Neuroradiol 2014 ; 35 : 1849-1857
 
3) Xiang, J et al : Newtonian viscosity model could overestimate wall shear stress in intracranial aneurysm domes and underestimate rupture risk. J Neurointerv Surg 2012 ; 4 : 351-357
 
4) Fukuda, S et al : Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation 2000 ; 101 : 2532-2538
 
5) Wang, Z et al : Molecular alterations associated with aneurysmal remodeling are localized in the high hemodynamic stress region of a created carotid bifurcation. Neurosurgery 2009 ; 65 : 169-177
 
6) Shojima, M et al : Role of shear stress in the blister formation of cerebral aneurysms. Neurosurgery 2010 ; 67 : 1268-1275
 
7) Kono, K et al : Hemodynamic characteristics at the rupture site of cerebral aneurysms : a case study. Neurosurgery 2012 ; 71 : E1202-E1209
 
8) Omodaka, S et al : Local hemodynamics at the rupture point of cerebral aneurysms determined by computational fluid dynamics analysis. Cerebrovasc Dis 2012 ; 34 : 121-129
 
9) Takao, H et al : Hemodynamic differences between unruptured and ruptured intracranial aneurysms during observation. Stroke 2012 ; 43 : 1436-1439
 
10) Sugiyama, S et al : Relative residence time prolongation in intracranial aneurysms : a possible association with atherosclerosis. Neurosurgery 2013 ; 73 : 767-776
 
11) Morita, A et al : The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med 2012 ; 366 : 2474-2482
 

IV. 無症候性脳血管障害の内科治療と管理

P.159 掲載の参考文献
1) Aichner, FT et al : High cardiovascular event rates in patients with asymptomatic carotid stenosis : the REACH Registry. Eur J Neurol 2009 ; 16 : 902-908
 
2) Dufouil, C et al : Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke : The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005 ; 112 : 1644-1650
 
3) Huang, MC et al : Paradoxical trends in the management of unruptured cerebral aneurysms in the united states : analysis of nationwide database over a 10-year period. Stroke 2011 ; 42 : 1730-1735
 
4) Morita, A et al : The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med 2012 ; 366 : 2474-2482
 
5) 脳ドックの新ガイドライン作成委員会編 : 脳ドックのガイドライン 2014, 改訂第4版, 響文社, 北海道, 2014
 
P.162 掲載の参考文献
1) Bernick, C et al : Silent MRI infarcts and the risk of future stroke : the Cardiovascular Health Study. Neurology 2001 ; 57 : 1222-1229
 
2) Prabhakaran, S et al : Prevalence and determinants of subclinical brain infarction : the Northern Manhattan Study. Neurology 2008 ; 70 : 425-430
 
3) Shiga, T et al : An analysis of risk factors for asymptomatic cerebral infarction. Intern Med 2008 ; 47 : 1-6
 
4) Vermeer, SE et al : Silent brain infarcts and white matter lesions increase stroke risk in the general population : the Rotterdam Scan Study. Stroke 2003 ; 34 : 1126-1129
 
5) Price, TR et al : Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 1997 ; 28 : 1158-1164
 
6) Vermeer, SE et al : Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2002 ; 33 : 21-25
 
7) Chodosh, EH et al : Silent stroke in the NINCDS Stroke Data Bank. Neurology 1988 ; 38 : 1674-1679
 
8) Kase, CS et al : Prevalence of silent stroke in patients presenting with initial stroke : the Framingham Study. Stroke 1989 ; 20 : 850-852
 
9) Shinohara, Y et al : Effect of the Ca antagonist nilvadipine on stroke occurrence or recurrence and extension of asymptomatic cerebral infarction in hypertensive patients with or without history of stroke (PICA Study). 1. Design and results at enrollment. Cerebrovasc Dis 2007 ; 24 : 202-209
PubMed
10) Baigent, C et al : Aspirin in the primary and secondary prevention of vascular disease : collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009 ; 373 : 1849-1860
 
11) Bartolucci, AA et al : Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. Am J Cardiol 2011 ; 107 : 1796-1801
 
12) Raju, N et al : Effect of aspirin on mortality in the primary prevention of cardiovascular disease. Am J Med 2011 ; 124 : 621-629
 
13) Ikeda, Y et al : Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors : a randomized clinical trial. JAMA 2014 ; 312 : 2510-2520
 
14) Uchiyama, S et al : Stroke prevention by cilostazol in patients with atherothrombosis : meta-analysis of placebo-controlled randomized trials. J Stroke Cerebrovasc Dis 2009 ; 18 : 482-490
 
P.167 掲載の参考文献
1) Roob, G et al : MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology 1999 ; 52 : 991-994
 
2) Chowdhury, MH et al : Age-related changes in white matter lesions, hippocampal atrophy, and cerebral microbleeds in healthy subjects without major cerebrovascular risk factors. J Stroke Cerebrovasc Dis 2011 ; 20 : 302-309
 
3) Schrag, M et al : Clinical associations of cerebral microbleeds on magnetic resonance neuroimaging. J Stroke Cerebrovasc Dis 2014 ; 23 : 2489-2497
 
4) Offenbacher, H et al : MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol 1996 ; 17 : 573-578
 
5) Lee, SH et al : Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging : analysis of risk factors for multifocal signal loss lesions. Stroke 2002 ; 33 : 2845-2849
 
6) 脳卒中合同ガイドライン委員会 : 脳卒中治療ガイドライン 2009, 第1版, 協和企画, 東京, 2009
 
7) Imaizumi, T et al : Dotlike hemosiderin spots on T2*-weighted magnetic resonance imaging as a predictor of stroke recurrence : a prospective study. J Neurosurg 2004 ; 101 : 915-920
 
8) Fan, TH et al : Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke 2003 ; 34 : 2459-2462
 
9) Knudsen, KA et al : Clinical diagnosis of cerebral amyloid angiopathy : validation of the Boston criteria. Neurology 2001 ; 56 : 537-539
 
10) Greenberg, SM et al : The clinical spectrum of cerebral amyloid angiopathy : presentations without lobar hemorrhage. Neurology 1993 ; 43 : 2073-2079
 
11) Yakushiji, Y et al : Distributional impact of brain microbleeds on global cognitive function in adults without neurological disorder. Stroke 2012 ; 43 : 1800-1805
 
12) Nakata-Kudo, Y et al : Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease. Dement Geriatr Cogn Disord 2006 ; 22 : 8-14
 
13) Charidimou, A et al : Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk. Front Neurol 2012 ; 3 : 133
PubMed
14) Lovelock, CE et al : Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage : a systematic review of published and unpublished studies. Stroke 2010 ; 41 : 1222-1228
 
15) Charidimou, A et al : Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke : systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2013 ; 84 : 277-280
 
16) McCarron, MO et al : Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage. Lancet Neurol 2004 ; 3 : 484-492
 
P.171 掲載の参考文献
1) 山口武典 : わが国の脳卒中診療の現状と21世紀の展望. 脳卒中 2001 ; 23 : 261-268
 
2) 湧川佳幸ほか : 病型別にみた脳梗塞危険因子の年代別・性別頻度. 脳卒中データバンク, 小林祥泰編, 中山書店, 東京, 2003, 30-31
 
3) Yamazaki, T et al : Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan. Circ J 2007 ; 71 : 995-1003
 
4) Steg, PG et al : One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007 ; 297 : 1197-1206
 
5) Slarl, J et al : Silent brain infarction in the presence of systemic vascular disease. JRSM Cardiovasc Dis 2012 ; 1 : 1-9
 
6) Yamada, N et al : Association between signal hyperintensity on T1-weighted MR imaging of carotid plaques and ipsilateral ischemic events. AJNR Am J Newroradiol 2007 ; 28 : 287-292
 
7) Amarenco, P et al : The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992 ; 326 : 221-225
 
8) Shimada, J et al : Features of brain magnetic resonance imaging diffusion-weighted images of aortogenic embolic stroke. Circ J 2014 ; 78 : 738-742
 
9) Fujimoto, S et al : Aortic arch atherosclerotic lesions and the recurrence of ischemic stroke. Stroke 2004 ; 35 : 1426-1429
 
10) Baigent, C et al : Aspirin in the primary and secondary prevention of vascular disease : collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009 ; 373 : 1849-1860
 
11) Toyoda, K et al : Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease : a prospective, multicenter, observational study. Stroke 2008 ; 39 : 1740-1745
 
P.178 掲載の参考文献
1) 国立障害者リハビリテーションセンター : 高次脳機能障害者支援の手引き. http://www.rehab.go.jp/ri/brain_fukyu/tebiki_all.pdf (2015年2月閲覧)
 
2) Kalaria, RN et al : Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 2004 ; 226 : 75-80
 
3) Wilkinson, D et al : Donepezil in vascular dementia : a randomized, placebo-controlled study. Neurology 2003 ; 61 : 479-486
 
4) Fioravanti, M et al : Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment. Cochrane Database of Syst Rev 2001 ; (4) : CD003159
PubMed
5) Lendrem, W et al : Spantaneous recovery of language in patients with aphasia between 4 and 34 weeks after stroke. J Neurol Neurosurg Psychiatry 1985 ; 48 : 743-748
 
6) 長田乾ほか : 失語症回復の脳内メカニズム. 神研の進歩 2003 ; 47 : 781-795
 
7) Robey, RR : The efficacy of treatment for aphasic persons : a meta-analysis. Brain Lang 1994 ; 47 : 582-608
 
8) Basso, A : 失語症治療へのアプローチ, 武田克彦訳, 中外医学社, 東京, 2007
 
9) Albert, ML et al : Pharmacotherapy for aphasia. Neurology 1998 ; 38 : 877-879
 
10) Sabe, L et al : A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia. Neurology 1995 ; 45 : 2272-2274
 
11) Berthier, ML et al : Memantine and constraint-induced aphasia therapy in chronic poststroke aphasia. Ann Neurol 2009 ; 65 : 577-585
 
12) Stone, SP et al : The assessment of visuo-spatial neglect after acute stroke. J Neurol Neurosurg Psychiatry 1991 ; 54 : 345-350
 
13) DeCarli, C : Clinically asymptomatic vascular brain injury : a potent cause of cognitive impairment among older individuals. J Alzheimers Dis 2013 ; 33 : S417-S426
 
P.181 掲載の参考文献
1) Kobayashi, S et al : Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997 ; 28 : 1932-1939
 
2) Vermeer, SE et al : Silent brain infarcts and white matter lesions increase stroke risk in the general population : the Rotterdam Scan Study. Stroke 2003 ; 34 : 1126-1129
 
3) 脳卒中合同ガイドライン委員会 : 脳卒中治療ガイドライン 2009, 協和企画, 東京, 2009, 227-229
 
4) Halliday, A et al : Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms : randomised controlled trial. Lancet 2004 ; 363 : 1491-1502
 
5) Abbott, AL : Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis : results of a systematic review and analysis. Stroke 2009 ; 40 : e573-e583
 
6) Hirt, LS : Progression rate and ipsilateral neurological events in asymptomatic carotid stenosis. Stroke 2014 ; 45 : 702-706
 
7) Mohr, JP et al : Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA) : a multicentre, non-blinded, randomised trial. Lancet 2014 ; 383 : 614-621
 
8) Gross, BA et al : Natural history of cerebral arteriovenous malformations : a meta-analysis. J Neurosurg 2013 ; 118 : 437-443
 
9) 脳卒中合同ガイドライン委員会 : 脳卒中治療ガイドライン 2009, 協和企画, 東京, 2009, 233-240
 
10) Morita, A et al : The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med 2012 ; 366 : 2474-2482
 
11) 脳ドックの新ガイドライン作成委員会編 : 未破裂脳動脈瘤の対応. 脳ドックのガイドライン 2014, 響文社, 北海道, 2014, 71-84
 
P.186 掲載の参考文献
1) Kawaguchi, M et al : Neuroprotective effects of anesthetic agents. J Anesth 2005 ; 19 : 150-156
 
2) Dinsmore, J : Anaesthesia for elective neurosurgery. Br J Anaesth 2007 ; 99 : 68-74
 
3) Lotto, ML et al : Effects of anesthetic agents and physiologic changes on intraoperative motor evoked potentials. J Neurosurg Anesthesiol 2004 ; 16 : 32-42
 

V. 各論 - 外科治療, 血管内治療の適応決定 -

P.193 掲載の参考文献
1) de Weerd, M et al : Prevalence of asymptomatic carotid artery stenosis in the general population : an individual participant data meta-analysis. Stroke 2010 ; 41 : 1294-1297
 
2) Balestrini, S et al : Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration. Neurology 2013 ; 80 : 2145-2150
 
3) Abbott, AL : Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis. Results of a systematic review and analysis. Stroke 2009 ; 40 : e573-e583
 
4) Raman, G et al : Management strategies for asymptomatic carotid stenosis : a systematic review and meta-analysis. Ann Intern Med 2013 ; 158 : 676-685
 
5) Hirt, LS : Progression rate and ipsilateral neurological events in asymptomatic carotid stenosis. Stroke 2014 ; 45 : 702-706
 
P.198 掲載の参考文献
1) Fukuhara, M et al : White-coat and masked hypertension are associated with carotid atherosclerosis in a general population : the Hisayama study. Stroke 2013 ; 44 : 1512-1517
 
2) Meschia, JF et al : Guidelines for the primary prevention of stroke : a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014 ; 45 : 3754-3832
 
3) Saito, K et al : Contrast-enhanced ultrasound for the evaluation of neovascularization in atherosclerotic carotid artery plaques. Stroke 2014 ; 45 : 3073-3075
 
4) Fukuda, K et al : Relationship between carotid artery remodeling and plaque vulnerability with T1-weighted magnetic resonance imaging. J Stroke Cerebrovasc Dis 2014 ; 23 : 1462-1470
 
5) Fiorella, D et al : A prospective, multicenter pilot study investigating the utility of flat detector derived parenchymal blood volume maps to estimate cerebral blood volume in stroke patients. J Neurointerv Surg 2014 ; 6 : 451-456
 
P.204 掲載の参考文献
1) Moussa, ID et al : Asymptomatic Carotid Artery Stenosis : A Primer on Risk : Stratification and Management, Informa Healthcare, London, 2007
 
2) Committee for the Asymptomatic Carotid Atherosclerosis Study : Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995 ; 273 : 1421-1428
 
3) Rijbroek, A et al : Asymptomatic carotid artery stenosis : past, present and future. Eur Neurol 2006 ; 56 : 139-154
 
4) Muluk, SC et al : Progression of asymptomatic carotid stenosis : A natural history study in 1004 patients. J Vasc Surg 1999 ; 29 : 208-214
 
5) Singh, N et al : Moderate carotid artery stenosis : MR imaging-depicted intraplaque hemorrhage predicts risk of cerebrovascular ischemic events in asymptomatic men. Radiology 2009 ; 252 : 502-508
 
6) Markus, HS et al : Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES) : a prospective observational study. Lancet Neurol 2010 ; 9 : 663-671
 
7) Topakian, R et al : Ultrasonic plaque echolucency and emboli signals predict stroke in asymptomatic carotid stenosis. Neurology 2011 ; 77 : 751-758
 
8) Kakkos SK et al : Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis. J Vasc Surg 2009 ; 49 : 902-909
 
9) Wong, KSL et al : Clopidogrel plus aspirin versus aspirin alone for reducing embolization in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study) : a randomised, open-label, blinded-endpoint trial. Lancet Neurol 2010 ; 9 : 489-497
 
P.209 掲載の参考文献
1) Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995 ; 273 : 1421-1428
 
2) Halliday, A et al : Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms : randomised controlled trial. Lancet 2004 ; 363 : 1491-1502
 
3) Yadav, JS et al : Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004 ; 351 : 1493-1501
 
4) Brott, TG et al : Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010 ; 363 : 11-23
 
5) Abbott, AL : Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis : results of a systematic review and analysis. Stroke 2009 ; 40 : e573-583
 
P.213 掲載の参考文献
1) Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995 ; 273 : 1421-1428
 
2) Halliday, A et al : Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms : randomised controlled trial. Lancet 2004 ; 363 : 1491-1502
 
3) Halliday, A et al : 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1) : a multicentre randomised trial. Lancet 2010 ; 376 : 1074-1084
 
4) den Hartog, AG et al : Risk of stroke from new carotid artery occlusion in the Asymptomatic Carotid Surgery Trial-1. Stroke 2013 ; 44 : 1652-1659
 
5) Abbott, AL : Medical (Nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis : results of a systematic review and analysis. Stroke 2009 ; 40 : e573-e583
 
P.218 掲載の参考文献
1) Silver, FL et al : Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke 2011 ; 42 : 675-680
 
2) 安部 洋ほか : CEAの手術手技. NS NOW 6 脳虚血の外科, 塩川芳昭編, メジカルビュー社, 東京, 2009, 95-102
 
3) 一ツ松勤 : 頚動脈内膜剥離術における脳・頚神経損傷の回避-外科解剖と手術手技-. No Shinkei Geka 2014 ; 42 : 817-828
 
4) 一ツ松勤ほか : CEA術後脳神経麻痺合併の回避 : 自験連続216例の検討. 脳卒中の外科 2015 ; 43 (in press)
 
P.224 掲載の参考文献
1) Brott, TG et al : Stenting and endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010 ; 363 : 11-23
 
2) Carotid Stenting Trialists' Collaboration : Short-term outcome after stenting versus endarterectmy for symptomatic carotid stenosis : a preplanned meta-analysis of individual patient data. Lancet 2010 ; 376 : 1062-1073
 
3) Naggara, O et al : Anatomical and technical factors associated with stroke or death during carotid angioplasty and stenting : results from the endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial and systematic review. Stroke 2011 ; 42 : 380-388
PubMed
4) Touze, E et al : A clinical rule (sex, contralateral occlusion, age, and restenosis) to select patients for stenting versus carotid endarterectomy : systematic review of observational studies with validation in randomized trials. Stroke 2013 ; 44 : 3394-3400
 
5) Krapf, H et al : Risk factors for periprocedural complications in carotid artery stenting without filter protection : A serial diffusion-weighted MRI study. J Neurol 2006 ; 253, 364-371
 
6) Biasi, GM et al : Carotid plaque echolucency increases the risk of stroke in carotid stenting : the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study. Circulation 2004 ; 110 : 756-762
 
7) Yoshimura, S et al : Staged angioplasty for carotid artery stenosis to prevent postoperative hyperperfusion. Neurosurgery 2009 ; 64 : ons122-ons129
 
8) Ogasawara, K et al : Cerebral hyperperfusion following carotid endarterectomy : Diagnostic utility of intraoperative transcranial Doppler ultrasonography compared with single-photon emission computed tomography study. Am J Neuroradiol 2005 ; 26 : 252-257
 
P.228 掲載の参考文献
1) Wong, KS et al : Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology 2007 ; 68 : 2035-2038
 
2) Lopez-Cancio, E et al : The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study : prevalence and risk factors. Atherosclerosis 2012 ; 221 : 221-225
 
3) Kremer, C et al : Prognosis of asymptomatic stenosis of the middle cerebral artery. Journal of neurology, neurosurgery, and psychiatry. 2004 ; 75 : 1300-1303
 
4) Kern, R et al : Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease. Neurology 2005 ; 65 : 859-864
 
5) The WASID trial investigators : Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology 2003 ; 22 : 106-117
 
P.233 掲載の参考文献
1) 篠原幸人ほか : 脳卒中治療ガイドライン 2009, 協和企画, 東京, 2009, 225-226
 
2) Chimowitz, MI et al : Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005 ; 352 : 1305-1316
 
3) Kwon, SU et al : Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis : the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 2005 ; 36 : 782-786
 
4) Kwon, SU et al : Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke 2011 ; 42 : 2883-2890
 
5) Derdeyn, CP et al : Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS) : the final results of a randomized trial. Lancet 2014 ; 383 : 333-341
 
6) Toyoda, K et al : Blood pressure levels and bleeding events during antithrombotic therapy : the Bleeding with Antithrombotic Therapy (BAT) Study. Stroke 2010 ; 41 : 1440-1444
 
P.239 掲載の参考文献
1) Aoki, T et al : Chronic inflammation in intracranial aneurysm formation. Inflammation Regenerat 2013 ; 33 : 283-287
 
2) 青木友浩 : 脳動脈瘤形成機序の最新の知見と脳動脈瘤治療法変革への展望. 先端医療シリーズ 45 臨床医のための最新脳神経外科, 橋本信夫ほか監修, (株) 寺田国際事務所/先端医療技術研究所, 東京, 2014, 179-183
 
3) Aoki, T et al : Targeting chronic inflammation in cerebral aneurysms focusing on NFκB as a putative target of medical therapy. Expert Opin Ther Targets 2010 ; 14 : 265-273
 
4) Aoki, T et al : Prostaglandins and chronic inflammation. Trends Pharmacol Sci 2012 ; 33 : 304-311
 
5) Yoshimura, Y et al : Statin use and risk of cerebral aneurysm rupture : a hospital-based case-control study in Japan. J Stroke Cerebrovasc Dis 2014 ; 23 : 343-348
 
P.242 掲載の参考文献
1) Inagawa, F et al : Autopsy study of unruptured incidental intracranial aneurysms. Surg Neurol 1990 ; 34 : 361-365
 
2) Vlak, MH et al : Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period : a systematic review and meta-analysis. Lancet Neurol 2011 ; 10 : 626-636
 
3) White, PM et al : Can noninvasive imaging accurately depict intracranial aneurysms? A systematic review. Radiology 2000 ; 217 : 361-370
 
4) Connolly, ES et al : Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage. Stroke 2012 ; 43 : 1711-1737
 
5) Xiang, J et al : Hemodynamic-morphologic discriminants for intracranial aneurysm rupture. Stroke 2011 ; 42 : 144-152
 
6) 日本脳ドック学会 : 未破裂脳動脈瘤の対応. 脳ドックのガイドライン 2014, 響文社, 札幌, 2014, 71-84
 
P.246 掲載の参考文献
1) Igase, K et al : Initial experience on evaluating prevalence of unruptured intracranial aneurysms detected on 3-tesra MRI. Cerebrovasc Dis 2012 ; 33 : 348-353)
 
2) Juvela, S et al : Factors affecting formation and growth of intracranial aneurysms : a long-term follow-up study. Stroke 2001 ; 32 : 485-491
 
3) Jeon, JS et al : A retrospective analysis on the natural history of incidental small paraclinoid unruptured aneurysm. J Neurol Neurosurg Psychiatry 2014 ; 85 : 289-294
 
4) Igase, M et al : Visit-to-visit variability in systolic blood pressure is a novel risk factor for the growth of intracranial aneurysms. Cerebrovasc Dis 2013 ; 36 : 401-406
 
5) Aoki, T et al : Pitavastatin suppresses the formation and progression of cerebral aneurysms through the inhibition of nuclear factor kappa B pathway. Neurosurgery 2009 ; 64 : 357-366
 
P.252 掲載の参考文献
1) Unruptured intracranial aneurysms-risk of rupture and risks of surgical intervention. International Study of Unruptured Intracranial Aneurysms Investigators. N Engl J Med 1998 ; 339 : 1725-1733
 
2) Wiebers, DO et al : Unruptured intracranial aneurysms : natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003 ; 362 : 103-110
 
3) Ishibashi, T et al : Unruptured intracranial aneurysms : incidence of rupture and risk factors. Stroke 2009 ; 40 : 313-316
 
4) Sonobe, M et al : Small unruptured intracranial aneurysm verification study : SUAVe study, Japan. Stroke 2010 ; 41 : 1969-1977
 
5) Morita, A et al : The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med 2012 ; 366 : 2474-2482
 
6) Juvela, S et al : Natural history of unruptured intracranial aneurysms : probability of and risk factors for aneurysm rupture. J Neurosurg 2008 ; 108 : 1052-1060
 
7) Nakano, K et al : The collagen-binding protein of Streptococcus mutans is involved in haemorrhagic stroke. Nat Commun 2011 ; 2 : 485
PubMed
8) Greving, JP et al : Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms : a pooled analysis of six prospective cohort studies. Lancet Neurol 2014 ; 13 : 59-66
 
P.256 掲載の参考文献
1) Guresir, E et al : Oculomotor nerve palsy by posterior communicating artery aneurysms-influences of surgical strategy on recovery. J Neurosurg 2012 ; 117 : 904-910
 
2) 松野治雄ほか : 後頭蓋窩とその近傍部脳槽の外科解剖. 顕微鏡下手術のための脳神経外科解剖, 小林茂昭編, サイメッドパブリケーションズ, 東京, 1989, 99-129
 
3) Kodama, N et al : Preservation of the arteries around an aneurysm-practical use of oxycellulose. J Neurosurg 1995 ; 83 : 748-749
 
4) 佐野公俊ほか : 巨大脳動脈瘤の手術. 脳外誌 1992 ; 1 : 339-347
 
5) 波出石弘ほか : 脳動脈瘤手術の工夫. 脳卒中の外 2006 ; 34 : 340-346
 
6) 卯田健ほか : 後頭蓋窩血栓化動脈瘤に対する複合治療-Ligation and embolization method. 脳外誌 2000 ; 9 : 556-560
 
P.261 掲載の参考文献
1) Delgado Almandoz, JE et al : Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms. J Neurointerv Surg 2014 ; 6 : 767-773
 
2) Kono, K et al : Hemodynamics of 8 different configurations of stenting for bifurcation aneurysms. AJNR Am J Neuroradiol 2013 ; 34 : 1980-1986
 
3) Lylyk, P et al : Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device : the Buenos Aires experience. Neurosurgery 2009 ; 64 : 632-642
 
4) Shigematsu, T et al : Endovascular therapy for asymptomatic unruptured intracranial aneurysms : JR-NET and JR-NET2 findings. Stroke 2013 ; 44 : 2735-2742
 
5) Pierot, L et al : Endovascular treatment of intracranial aneurysm. Current status. Stroke 2013 ; 44 : 2046-2054
 
6) Ferns, SP et al : Coiling of intracranial aneurysms : a systematic review on initial occlusion and reopening and retreatment rates. Stroke 2009 ; 40 : e523-e529
 
P.265 掲載の参考文献
1) Wiebers, DO et al : Unruptured intracranial aneurysms : Natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003 ; 362 : 103-110
 
2) Tuffiash, E et al : Craniotomy for treatment of unruptured aneurysms is not associated with long-term cognitive dysfunction. Stroke 2003 ; 34 : 2195-2199
PubMed
3) Otawara, Y et al : Cognitive function before and after surgery in patients with unruptured intracranial aneurysm. Stroke 2005 ; 36 : 142-143
 
4) Kubo, Y et al : Cognitive function and anxiety before and after surgery for asymptomatic unruptured intracranial aneurysms in elderly patients. World Neurosurg 2010 ; 73 : 350-353
 
5) Preiss, M et al : Cognitive functions before and 1 year after surgical and endovascular treatment in patients with unruptured intracranial aneurysms. B J Neurosurg 2012 ; 26 : 514-516
 
6) Pereira-Filho, AA et al : Long-term behavioral and cognitive outcomes following clipping for incidental unruptured intracranial aneurysms. Neuropsychology 2014 ; 28 : 75-83
 
7) Shibahashi, K et al : Does a craniotomy for treatment of unruptured aneurysm affect cognitive function? Neurol Med Chir 2014 ; 54 : 786-793
 
8) 山城重雄ほか : 患者の術前後および長期QOLからみた無症候性未破裂脳動脈瘤治療の妥当性. 脳卒中の外科 2005 ; 33 : 8-13
 
9) Brilstra, EH et al : Quality of life after treatment of unruptured intracranial aneurysms by neurosurgical clipping or by embolisation with coils. A prospective, observational study. Cerebrovasc Dis 2004 ; 17 : 44-52
PubMed
10) Raaymakers, TW et al : Functional outcome and quality of life after angiography and operation for unruptured intracranial aneurysms. On behalf of the mars study group. J Neurol Neurosurg Psychiatry 2000 ; 68 : 571-576
 
11) Morita, A et al : The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med 2012 ; 366 : 2474-2482
 
12) Suzuki, M et al : Adverse events after unruptured cerebral aneurysm treatment : A single-center experience with clipping/coil embolization combined units. J Stroke Cerebrovasc Dis 2015 ; 24 : 223-231
 
P.269 掲載の参考文献
1) Robinson, JR et al : Natural history of the cavernous angioma. J Neurosurg 1991 ; 75 : 709-714
 
2) Otten, P et al : 131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies. Neurochirurgie 1989 ; 35 : 82-83
 
3) Moran, NF et al : Supratentorial cavernous haemangioblastoma and epilepsy : a review of the literature and case series. J Neurol Neurosurg Psychiatry 1999 ; 66 : 561-568
 
4) Krisht, KM et al : The pathogenetic features of cerebral cavernous malformations : a comprehensive review with therapeutic implications. Neurosurg Focus 2010 ; 29 : E2
PubMed
5) Yalda, S et al : Cerebral cavernous malfprmations as a disease of vascular permeability : from bench to bedside with caution. Neurosurg Focus 2010 ; 29 : E4
 
6) Labauge, P et al : Genetics of cavernous angioma. Lancet Neurol 2007 ; 6 : 237-244
 
7) Aiba, T et al : Natural history of intracranial cavernous malformations. J Neurosurg 1995 ; 83 : 56-59
 
8) Kondziolka, D et al : The Natural history of cerebral cavernous malformations. J Neurosurg 1995 ; 83 : 820-824
 
9) Al-Shahi Salmon, R et al : Untreated clinical course of cerebral cavernous malformations : a prospective, population-based cohort study. Lancet Neurol 2012 ; 11 : 217-224
 
10) Del Curling, O Jr et al : An analysis of natural history of cavernous angiomas. J Neurosurg 1991 ; 75 : 702-708
 
11) Moriarity, JL et al : The natural history of cavernous malformations : a prospective study of 68 patients. Neurosurgery 1999 ; 44 : 1166-1173
 
12) Clatterbuck, RE et al : Dynamic nature of cavernous malformations : a prospective magnetic resonance imaging study with volumetric analysis. J Neurosurg 2000 ; 93 : 981-986
 
P.273 掲載の参考文献
1) Porter, PJ et al : Cerebral cavernous malformations : natural history and prognosis after clinical deterioration with or without hemorrhage. J Neurosug 1997 ; 87 : 190-197
PubMed
2) Lasjaunias, P et al : Developmental venous anomalies (DVA) : the so-called venous angioma. Neurosurg Rev 1986 ; 9 : 233-242
 
3) Osborne, AG : Cavernous malformation. Diagnostic Imaging : Brain, 2nd ed, Osborne, AG ed, Amirsys Inc, Salt Lake City, 2010
 
4) Zabramski, JM et al : The natural history of familial cavernous malformations : results of an ongoing study. J Neurosurg 1994 ; 80 : 422-432
 
5) de Champfleur, NM et al : Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery 2011 ; 68 : 641-648
 
6) 斎藤健二ほか : ここまできた高磁場磁化率強調画像-脳神経領域. 3T MRIによるSWIの原理と撮像法. INNERVISION 2009 ; 24 (9) : 16-20
 
P.279 掲載の参考文献
1) Gunel, M et al : A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med 1996 ; 334 : 946-951
 
2) Denier, C et al : Clinical features of cerebral cavernous malformations patients with KRIT1 mutations. Ann Neurol 2004 ; 55 : 213-220
 
3) Labauge, P et al : Genetics of cavernous angiomas. Lancet Neurol 2007 ; 6 : 237-244
 
4) Pagenstecher, A et al : A two-hit mechanism causes cerebral cavernous malformations : complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum Mol Genet 2009 ; 18 : 911-918
PubMed
5) Cavalcanti, DD et al : Cerebral cavernous malformations : from genes to proteins to disease. J Neurosurg 2012 ; 116 : 122-132
 
6) McCormick, WF : The pathology of vascular ("arteriovenous") malformations. J Neurosurg 1966 ; 24 : 807-816
 
7) 高木健治ほか : 海綿状血管奇形の特徴と治療. 脳外誌 2013 ; 22 : 28-36
 
P.283 掲載の参考文献
1) Plate, KH : Mechanism of angiogenesis in the brain. J Neuropathol Exp Neurol 1999 ; 58 : 313-320
 
2) Ogilvy, CS et al : AHA scientific statement. Recommendations for the management of intracranial arteriovenous malformations. Stroke 2001 ; 32 : 1458-1471
 
3) Gross, BA et al : The natural history of cerebral arteriovenous malformations : a meta-analysis. J Neurosurg 2013 ; 118 : 437-443
 
4) Kondziolka, D et al : Simple risk prediction for arteriovenous malformation hemorrhage. Neurosurgery 1995 ; 37 : 851-855
 
5) Josephson, CB et al : Seizure risk from cavernous or arteriovenous malformations : prospective population-based study. Neurology 2011 ; 76 : 1548-1554
 
P.287 掲載の参考文献
1) Buis, DR et al : Brain arteriovenous malformations : from diagnosis to treatment. J Neurosurg Sci 2011 ; 55 : 39-56
 
2) 小宮山雅樹 : 異なる視点からみた脳動静脈奇形の疾患概念. 脳外誌 2011 ; 20 : 4-11
 
3) 小宮山雅樹 : 脳動静脈奇形. 遺伝性出血性末梢血管拡張症 (HHT) の診療マニュアル, 塩谷隆信編, 中外医学社, 2011, 128-134
 
P.292 掲載の参考文献
1) Mohr, JP et al : Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA) : a multicentre, non-blinded, randomised trial. Lancet 2014 ; 383 : 614-621
 
2) Starke, RM et al : Treatment guidelines for cerebral arteriovenous malformation microsurgery. Br J Neurosurg 2009 ; 23 : 376-386
 
3) Sanchez-Mejia, RO et al : Superior outcomes in children compared with adults after microsurgical resection of brain arteriovenous malformations. J Neurosurg 2006 ; 105 (2 Suppl) : 82-87
 
4) Lawton, MT et al : A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery 2010 ; 66 : 702-713 ; discussion 713
 
P.296 掲載の参考文献
1) 冨永悌二 : 脳動静脈奇形の外科治療・血管内治療. 脳外誌 2011 ; 20 : 29-36
 
2) Oglivy, CS et al : Recommendations for the management of intracranial arteriovenous malformations : a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Circulation 2001 ; 103 : 2644-2657
 
3) Mohr, JP et al : Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA) : a multicentre, non-blinded, randomised trial. Lancet 2014 ; 383 : 614-621
 
P.300 掲載の参考文献
1) Mohr, JP et al : Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA) : A multicentre, non-blinded, randomised trial. Lancet 2014 ; 383 : 614-621
 
2) Stapf, C et al : Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 2006 ; 66 : 1350-1355
 
3) Al-Shahi Salman, R et al : Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. JAMA 2014 ; 311 : 1661-1669
 
4) Ogilvy, CS et al : AHA Scientific Statement : Recommendations for the management of intracranial arteriovenous malformations : A statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke 2001 ; 32 : 1458-1471
 
5) Rutledge, WC et al : Treatment and outcomes of aruba-eligible patients with unruptured brain arteriovenous malformations at a single institution. Neurosurg Focus 2014 ; 37 : E8
 
6) Pollock, BE et al : The risk of stroke or clinical impairment after stereotactic radiosurgery for aruba-eligible patients. Stroke 2013 ; 44 : 437-441
 
7) Ding, D et al : Radiosurgery for patients with unruptured intracranial arteriovenous malformations. J Neurosurg 2013 ; 118 : 958-966
 
8) Han, PP et al : Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations : Natural history and treatment paradigm. J Neurosurg 2003 ; 98 : 3-7
 
9) Jayaraman, MV et al : Hemorrhage rate in patients with Spetzler-Martin grades IV and V arteriovenous malformations : Is treatment justified? Stroke 2007 ; 38 : 325-329
 
10) Moosa, S et al : Volume-staged versus dose-staged radiosurgery outcomes for large intracranial arteriovenous malformations. Neurosurg Focus 2014 ; 37 : E18
PubMed
P.305 掲載の参考文献
1) Mohr, JP et al : Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA) : a multicentre, non-blinded, randomised trial. Lancet 2014 ; 383 : 614-621
 
2) Wedderburn, CJ et al : Outcome after interventional or conservative management of unruptured brain arteriovenous malformations : a prospective, population-based cohort study. Lancet Neurol 2008 ; 7 : 223-230
 
3) Laakso, A et al : Long-term excess mortality in 623 patients with brain arteriovenous malformations. Neurosurgery 2008 ; 63 : 244-253
 
4) van Beijnum, J et al : Treatment of brain arteriovenous malformations : a systematic review and meta-analysis. JAMA 2011 ; 306 : 2011-2019
 
5) Al-Shahi Salman, R et al : Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. JAMA 2014 ; 311 : 1661-1669
 
6) Stapf, C et al : Management of brain arteriovenous malformations-authors' reply. Lancet 2014 ; 383 : 1635-1636
 
P.309 掲載の参考文献
1) Borden, JA et al : A proposed classification for spinal and cranial dural arteriovenous fistulous malformation and implications of treatment. J Neurosurg 1995 ; 82 : 166-179
 
2) Cognard, C et al : Cerebral dural arteriovenous fistulas : clinical and angiographic correlation with a revised classification of venous drainage. Radiology 1995 ; 194 : 671-680
 
3) Zipfel, GJ et al : Cranial dural arteriovenous fistulas : modification of angiographic classification scales based on new natural history data. Neurosurg Focus 2009 ; 26 : E14
PubMed
4) Lalwani, AK et al : Grading venous restrictive disease in patients with dural arteriovenous fistulas of the transverse/sigmoid sinus. J Neurosurg 1993 ; 79 : 11-15
 
5) Geibprasert, S et al : Dural arteriovenous shunts. A new classification of craniospinal epidural venous anatomical bases and clinical correlations. Stroke 2008 ; 39 : 2783-2794
 
6) Piton, J et al : Fistulae of the lateral sinus. J Neuroradiol 1984 ; 11 : 143-159
 
7) Cognard, C et al : Cerebral dural arteriovenous fistulas : clinical and angiographic correlation with a revised classification of venous drainage. Radiology 1995 ; 194 : 671-680
 
8) Satomi, J et al : Benign cranial dural arteriovenous fistulas : outcome of conservative management based on the natural history of the lesion. J Neurosurg 2002 ; 97 : 767-770
 
9) Shah, MN et al : Borden-Shucart Type I dural arteriovenous fistulas : clinical course including risk of conversion to higher-grade fistulas. J Neurosurg 2012 ; 117 : 539-545
 
10) van Dijk, JM et al : Clinical course of cranial dural arteriovenous fistulas with long-term persistent cortical venous reflux. Stroke 2002 ; 33 : 1233-1236
 
11) Duffau, H et al : Early rebleeding from intracranial dural arteriovenous fistulas. J Neurosurg 1999 ; 90 : 78-84
 
12) Bulters, DO et al : The natural history of cranial dural arteriovenous fistulae with cortical venous reflux-the significance of venous ectasia. Neurosurgery 2012 ; 70 : 312-318
 
13) Gross, BA et al : The natural history of cerebral dural arteriovenous fistulae. Neurosurgery 2012 ; 71 : 594-603
 
14) Soderman, M et al : Natural history of dural arteriovenous shunts. Stroke 2008 ; 39 : 1735-1739
 
15) Strom, RG et al : Cranial dural arteriovenous fistulae : asymptomatic cortical venous drainage portends less aggressive clinical course. Neurosurgery 2009 ; 64 : 241-247
 
16) Satomi, J et al : Predictability of the future development of aggressive behavior of cranial dural arteriovenous fistulae based on decision tree analysis. J Neurosurg [Epub ahead of print]
 
17) Satomi, J et al : Angiographic changes in venous drainage of cavernous sinus dural arteriovenous fistulae after palliative transarterial embolization or observational management : a proposed stage classification. Neurosurgery 2005 ; 56 : 494-502
PubMed
18) Suh, DC et al : New concept in cavernous sinus dural arteriovenous fistula : correlation with presenting symptom and venous drainage patterns. Stroke 2005 ; 36 : 1134-1139
 
P.314 掲載の参考文献
1) Nakagawa, I et al : The use of susceptibility-weighted imaging as an indicator of retrograde leptomeningeal venous drainage and venous congestion with dural arteriovenous fistula : diagnosis and follow-up after treatment. Neurosurgery 2013 ; 72 : 47-54 ; discussion 55
 
2) Kiyosue, H et al : Angioarchitecture of transverse-sigmoid sinus dural arteriovenous fistulas : evaluation of shunted pouches by multiplanar reformatted images of rotational angiography. AJNR Am J Neuroradiol 2013 ; 34 : 1612-1620
 
3) Borden, JA et al : A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg 1995 ; 82 : 166-179
 
4) Gross, BA et al : The natural history of cerebral dural arteriovenous fistulae. Neurosurgery 2012 ; 71 : 594-602 ; discussion 602-603
 
5) Shah, MN et al : Borden-Shucart Type I dural arteriovenous fistulas : clinical course including risk of conversion to higher-grade fistulas. J Neurosurg 2012 ; 117 : 539-545
 
P.320 掲載の参考文献
1) 杉生憲志ほか : 頭蓋内硬膜動静脈瘻の分類と治療. 脳外誌 2013 ; 22 : 37-43
 
2) Borden, JA et al : A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg 1995 ; 82 : 166-179
 
3) Cognard, C et al : Cerebral dural arteriovenous fistulas : clinical and angiographic correlation with a revised classification of venous drainage. Radiology 1995 ; 194 : 671-680
 
4) Zipfel, GJ et al : Cranial dural arteriovenous fistulas : modification of angiographic classification scales based on new natural history data. Neurosurg Focus 2009 ; 6 : E14
PubMed
5) Sugiu, K et al : Triple-catheter technique in the transvenous coil embolization of an isolated sinus dural arteriovenous fistula. Neurosurgery 2007 ; 61 : 81-85
 
P.323 掲載の参考文献
1) 厚生労働省ウイリス動脈輪閉塞症における病態・治療に関する研究班 : もやもや病 (ウイリス動脈輪閉塞症) 診断・治療ガイドライン. 脳卒中の外 2009 ; 37 : 321-337
 
2) Miyamoto, S et al : Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease : Results of the Japan Adult Moyamoya trial. Stroke 2014 ; 45 : 1415-1421
 
3) Kuroda, S et al : Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease : results of multicenter survey in Japan. Stroke 2007 ; 38 : 1430-1435
 
4) Narisawa, A et al : Efficacy of the revascularization surgery for adult-onset moyamoya disease with the progression of cerebrovascular lesions. Clin Neurol Neurosurg 2009 ; 111 : 123-126
 
P.328 掲載の参考文献
1) 峰晴陽平ほか : Mysterin遺伝子ともやもや病. 医学のあゆみ 2012 ; 242 : 948-949
 
2) Miyatake, S et al : Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G > A variant in RNF213 showed varying clinical course and severity. J Hum Genet 2012 ; 57 : 804-806
 
3) Morito, D et al : Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state. Sci Rep 2014 ; 4 : 4442
PubMed
4) Miyawaki, S et al : Genetic variant RNF213 c.14576G > A in various phenotypes of intracranial major artery stenosis/occlusion. Stroke 2013 ; 44 : 2894-2897
 
P.334 掲載の参考文献
1) Suzuki, J et al : Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969 ; 20 : 288-299
 
2) Liu, W et al : Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 2011 ; 6 : e22542
PubMed
3) Kuroda, S et al : Moyamoya disease : current concepts and future perspectives. Lancet Neurol 2008 ; 7 : 1056-1066
 
4) Miyamoto, S et al : Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease : results of the Japan adult moyamoya trial. Stroke 2014 ; 45 : 1415-1421
 
5) AMORE Study Group : 無症候性もやもや病の予後と治療法の確立をめざした多施設共同研究-AMORE研究について. 脳卒中の外 2013 ; 41 : 235-239
 
6) Kuroda, S et al : Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease : results of multicenter survey in Japan. Stroke 2007 ; 38 : 1430-1435
 
7) 山田勝 : 無症候性もやもや病の臨床像と予後-全国アンケート調査の結果をもとに. 脳外 2005 ; 33 : 337-342
 
8) Baba, T et al : Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 2008 ; 79 : 900-904
 
9) 難波理奈ほか : 成人無症候性もやもや病の臨床像と予後. 脳外 2003 ; 31 : 1291-1295
 
10) 厚生労働科学研究費補助金・難治性疾患克服事業「ウイリス動脈輪閉塞症における病態・治療に関する研究班」 : もやもや病 (ウイリス動脈輪閉塞症) 診断・治療ガイドライン. 脳卒中の外 2009 ; 37 : 321-327
 
11) 川合かがり : 病期が進行した無症候成人もやもや病に対する脳血行再建術 : 2例報告. 脳外 2010 ; 38 : 825-830
 
12) Kuroda, S et al : Incidence, locations, and longitudinal course of silent microbleeds in moyamoya disease : a prospective T2*-weighted MRI study. Stroke 2013 ; 44 : 516-518
 
P.338 掲載の参考文献
1) 山浦 晶ほか : 非外傷性頭蓋内解離性動脈病変の全国調査 (第1報). 脳卒中の外 1998 ; 26 : 79-86
 
2) 蓮江正道ほか : 解離性椎骨動脈瘤の治療. 脳卒中の外 1993 ; 21 : 361-367
 
3) 八木伸一ほか : 疼痛発症頭蓋内解離性椎骨動脈瘤の治療方針. 脳卒中の外 2005 ; 33 : 14-19
 
4) Mizutani, T : Natural course of intracranial arterial dissections. J Neurosurg 2011 ; 114 : 1037-1044
 
5) Mizutani, T et al : Proposed classification of nonatherosclerotic cerebral fusiform and dissecting aneurysms. Neurosurgery 1999 ; 45 : 253-259
 
P.342 掲載の参考文献
1) Ferro, LM et al : Prognosis of cerebral vein and dural sinus thrombosis : results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004 ; 35 : 664-670
 
2) Einhaupl, KM et al : Heparin treatment in sinus venous thrombosis. Lancet 1991 ; 338 : 597-600
 
3) de Bruijn, SF et al : Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999 ; 30 : 484-488
 
4) Ferro, JM et al : Decompressive surgery in cerebrovenous thrombosis : a multicenter registry and a systematic review of individual patient data. Stroke 2011 ; 42 : 2825-2831
 
5) Wasay, M et al : Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis. Stroke 2001 ; 32 : 2310-2317
 
6) Haghighi, AB et al : Mechanical thrombectomy for cerebral venous sinus thrombosis : a comprehensive literature review. Clin Appl Thromb Hemost 2013 ; 20 : 507-515
 

VI. 無症候性脳血管障害が与える影響

P.351 掲載の参考文献
1) 大槻美佳 : 多発性硬化症の認知機能障害の特徴. 神経内科 2014 ; 80 : 562-568
 
2) Baddeley, AD : The episodic buffer : a new component of working memory? Trends Cogn Sci 2000 ; 4 : 417-423
 
3) 日本神経学会 : 血管性認知症. 認知症疾患治療ガイドライン 2010. http://www.neurology-jp.org/guidelinem/degl/sinkei_degl_2010_07.pdf (2015年2月閲覧)
 
4) Nasreddine, ZS et al : The Montreal Cognitive Assessment, MoCA : A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005 ; 53 : 695-699
 
5) 鈴木宏幸ほか : Montreal Cognitive Assessment (MoCA) の日本語版作成とその有効性について. 老年精医誌 2010 ; 21 : 198-202
 
6) Folstein, MF et al : "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975 ; 12 : 189-198
 
P.357 掲載の参考文献
1) Guyatt, GH et al : Measuring health-related quality of life. Ann Intern Med 1993 ; 118 : 622-629
 
2) 竹上未紗ほか : 誰も教えてくれなかったQOL活用法, 第2版, 健康医療評価研究機構, 京都, 2012
 
3) Yamashiro, S et al : Improvement of quality of life in patients surgically treated for asymptomatic unruptured intracranial aneurysms. J Neurol Neurosurg Psychiatry 2007 ; 78 : 497-500
 
4) ピーター・M・フェイヤーズほか : QOL評価学 測定, 解析, 解釈のすべて, 福原俊一ほか監訳, 中山書店, 東京, 2005
 
5) Brazier, JE et al : Estimating a preference-based index from the Japanese SF-36. J Clin Epidemiol 2009 ; 62 : 1323-1331
 
P.362 掲載の参考文献
1) Rahman, M et al : Establishing standard performance measures for adult brain tumor patients : a Nationwide Inpatient Sample database study. Neuro Oncol 2013 ; 15 : 1580-1588
 
2) Takao, H et al : Treatment of unruptured intracranial aneurysms : decision and cost-effectiveness analysis. Radiology 2007 ; 244 : 755-766
 
3) Greving, JP et al : Cost-effectiveness of preventive treatment of intracranial aneurysms : new data and undertainties. Neurology 2009 ; 73 : 258-265
 
4) Takao, H et al : Cost-effectiveness of treatment of unruptured intracranial aneurysms in patients with a history of subarachnoid hemorrhage. Acad Radiol 2008 ; 15 : 1126-1132
 
5) Yoshimoto, Y et al : Cost-effectiveness analysis of screening for asymptomatic, unruptured intracranial aneurysms. A mathematical model. Stroke 1999 ; 30 : 1621-1627
 
6) Johnston, SC et al : Which unruptured cerebral aneurysms should be treated? A cost-utility analysis. Neurology 1999 ; 52 : 1806-1815
 
7) Takao, H et al : Screening for familial intracranial aneurysms : decision and cost-effectiveness analysis. Acad Radiol 2008 ; 15 : 462-471
 

書評

最近チェックした商品履歴

Loading...